Article thumbnail

Microbial Induction of Immunity, Inflammation, and Cancer

By Julia B. Greer and Stephen John O'Keefe

Abstract

The human microbiota presents a highly active metabolic that influences the state of health of our gastrointestinal tracts as well as our susceptibility to disease. Although much of our initial microbiota is adopted from our mothers, its final composition and diversity is determined by environmental factors. Westernization has significantly altered our microbial function. Extensive experimental and clinical evidence indicates that the westernized diet, rich in animal products and low in complex carbohydrates, plus the overuse of antibiotics and underuse of breastfeeding, leads to a heightened inflammatory potential of the microbiota. Chronic inflammation leads to the expression of certain diseases in genetically predisposed individuals. Antibiotics and a “clean” environment, termed the “hygiene hypothesis,” has been linked to the rise in allergy and inflammatory bowel disease, due to impaired beneficial bacterial exposure and education of the gut immune system, which comprises the largest immune organ within the body. The elevated risk of colon cancer is associated with the suppression of microbial fermentation and butyrate production, as butyrate provides fuel for the mucosa and is anti-inflammatory and anti-proliferative. This article will summarize the work to date highlighting the complicated and dynamic relationship between the gut microbiota and immunity, inflammation and carcinogenesis

Topics: Physiology
Publisher: Frontiers Research Foundation
OAI identifier: oai:pubmedcentral.nih.gov:3059938
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2001). A critical review of epidemiological studies in inflammatory bowel disease.
  2. (2009). A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses.
  3. (2008). A microbial symbiosis factor prevents intestinal inflammatory disease.
  4. (2006). Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.
  5. (2006). Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients.
  6. (2005). An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system.
  7. (2006). An overview of apoptosis and the prevention of colorectal cancer.
  8. (2009). Antibiotic use in children is associated with increased risk of asthma.
  9. (2000). Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: correlation with colon cancer inhibition.
  10. (2011). Association between low colonic short chain fatty acids and high bile acids in high colon cancer risk populations.
  11. (2003). Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice.
  12. (2006). Bile salt biotransformations by human intestinal bacteria.
  13. (2000). Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn’s disease.
  14. (2010). Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency.
  15. (2004). Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.
  16. (2009). Clostridium difficile and inflammatory bowel disease.
  17. (1993). Colonic epithelial metabolism in ulcerative colitis.
  18. (1988). Competition for hydrogen between sulphatereducing bacteria and methanogenic bacteria from the human large intestine.
  19. (2008). Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  20. (2008). Consumption of organic foods and risk of atopic disease during the first 2 years of life in the Netherlands.
  21. (2000). Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans.
  22. (1981). Diet and excretion of bile acids.
  23. (1997). Dietary fat and asthma: is there a connection?
  24. (2008). Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases.
  25. (2001). Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing.
  26. (2006). Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2.
  27. (1998). Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats.
  28. (2006). Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish–Danish twin population.
  29. (1996). Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan.
  30. (2002). Epidemiology of inflammatory bowel disease.
  31. (2005). Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.
  32. (2006). Factors influencing the composition of the intestinal microbiota in early infancy.
  33. (2008). Faecalibacterium prausnitzii is an antiinflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
  34. (2007). Folate production by bifidobacteria as a potential probiotic property.
  35. (1989). Hay fever, hygiene, and household size.
  36. (1998). High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan.
  37. (2007). Hydrogen sulfide induces direct radicalassociated DNA damage.
  38. (2003). Immunological effects of probiotics with special reference to lactobacilli.
  39. (2008). Immunomodulatory effects of probiotics in the intestinal tract.
  40. (2010). Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.
  41. (2002). Inflammation and cancer.
  42. (2004). Influence of mode of delivery on gut microbiota composition in seven year old children.
  43. (1976). Interactions between H2-producing and methane producing species,” in Microbial Formation and Utilization of Gases, eds
  44. (2003). Intestinal bacteria and ulcerative colitis.
  45. (2000). Isolation and characterization of cholic acid 7alpha-dehydroxylating fecal bacteria from cholesterol gallstone patients.
  46. (2006). Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis.
  47. (2002). Manipulation of colonic bacteria and volatile fatty acid production by dietary high amylose maize (amylomaize) starch granules.
  48. (2010). Meat and cancer.
  49. (2008). Methane formation in sewer systems.
  50. (2011). Microbial induction of immunity, inflammation, and cancer.
  51. (2007). Molecularphylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.
  52. (2000). Nonsteroidal anti-inflammatory drugs and cancer prevention.
  53. (2010). paper pending published: 29
  54. (2001). Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.
  55. (2009). Products of the colonic microbiota mediate the effects of diet on colon cancer risk.
  56. (2001). Rates of IBD in modernized nations are rising. Between the 1950s and 1990s, the incidence of Crohn’s disease nearly tripled in Northern Europe (Farrokhyar et al.,
  57. (2008). Reduced diversity in the early fecal microbiota of infants with atopic eczema.
  58. (2009). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
  59. (1995). Role of bile acids in colorectal carcinogenesis.
  60. (1992). Role of dietary sulphate in the regulation of methanogenesis in the human large intestine.
  61. (2005). Role of inflammation in pancreatic carcinogenesis and the implications for future therapy.
  62. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.
  63. (2009). Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines.
  64. (2001). Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides.
  65. (2010). Shortchain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats.
  66. (2007). Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth.
  67. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine.
  68. (1993). Sulphate reducing bacteria and hydrogen metabolism in the human large intestine.
  69. (2001). The African way of life and colon cancer risk.
  70. (1981). The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today.
  71. (2008). The differentiation of IL -17-producing T-helper cells in the lamina propria of the small intestine requires commensal cytophaga– flavobacter–bacteroidetes bacteria and can be inhibited with antibiotics Ivanov
  72. (2002). The effect of infections on susceptibility to autoimmune and allergic diseases.
  73. (2006). The epidemiology of inflammatory bowel disease in Canada: a populationbased study.
  74. (1983). The fat and the thin – a survey of nutritional status and disease patterns among urbanized Black South Africans.
  75. (2010). The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease.
  76. (2008). The incidence of Crohn’s disease in Cardiff over the last 75 years: an update for 1996-2005.
  77. (2009). The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis.
  78. (2002). The microbiology of butyrate formation in the human colon.
  79. (2007). The role of microbes in Crohn’s disease.
  80. (2009). The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
  81. (1990). Ulcerative colitis and colorectal cancer. A populationbased study.
  82. (2007). Why do African Americans get more colon cancer than Native Africans?